Final results of ARIEL2 (Part 1): A phase 2 trial to prospectively identify ovarian cancer (OC) responders to rucaparib using tumor genetic analysis

Date 29 September 2015
Event European Cancer Congress 2015
Session Gynaecological Cancer
Topics Ovarian Cancer
Presenter Kristeleit, R.